Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/20/2021 | $11.00 → $19.00 | Buy | HC Wainwright & Co. |
HC Wainwright & Co. reiterated coverage of Aridis Pharmaceuticals with a rating of Buy and set a new price target of $19.00 from $11.00 previously
Northland Securities resumed coverage of Aridis Pharmaceuticals with a rating of Buy and set a new price target of $22.00
Roth Capital resumed coverage of Aridis Pharmaceuticals with a rating of Buy and set a new price target of $18.00
4 - Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)
4 - Aridis Pharmaceuticals, Inc. (0001614067) (Issuer)